BioVie Inc. Warrant
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to mo… Read more
Market Cap & Net Worth: BioVie Inc. Warrant (BIVIW)
BioVie Inc. Warrant (NASDAQ:BIVIW) has a market capitalization of $3.19K ($3.19K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #46627 globally and #14509 in its home market, demonstrating a 6.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioVie Inc. Warrant's stock price $0.35 by its total outstanding shares 9125 (9.12K).
BioVie Inc. Warrant Market Cap History: 2025 to 2026
BioVie Inc. Warrant's market capitalization history from 2025 to 2026. Data shows growth from $2.35K to $3.19K (0.00% CAGR).
BioVie Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioVie Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIVIW by Market Capitalization
Companies near BioVie Inc. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to BioVie Inc. Warrant by market ranking:
- Tan Delta Systems PLC (LSE:TAND): Ranked #46618 globally with a market cap of $3.30K USD ( GBX27.09 Million GBX).
- Ellies (JSE:ELI): Ranked #46619 globally with a market cap of $3.30K USD ( ZAC6.20 Million ZAC).
- L.K. TECHNOLOGY (BE:L5D): Ranked #46628 globally with a market cap of $3.27K USD ( €3.19K EUR).
- Travel Investment and Seafood Development Corp (VN:DAT): Ranked #46629 globally with a market cap of $3.27K USD ( ₫83.04 Million VND).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #46618 | Tan Delta Systems PLC | LSE:TAND | $3.30K | GBX33.00 |
| #46619 | Ellies | JSE:ELI | $3.30K | ZAC0.01 |
| #46628 | L.K. TECHNOLOGY | BE:L5D | $3.27K | €0.35 |
| #46629 | Travel Investment and Seafood Development Corp | VN:DAT | $3.27K | ₫8350.00 |
BioVie Inc. Warrant Historical Marketcap From 2025 to 2026
Between 2025 and today, BioVie Inc. Warrant's market cap moved from $2.35K to $ 3.19K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.19K | +36.13% |
| 2025 | $2.35K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioVie Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.19K USD |
| MoneyControl | $3.19K USD |
| MarketWatch | $3.19K USD |
| marketcap.company | $3.19K USD |
| Reuters | $3.19K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.